350 related articles for article (PubMed ID: 28859612)
1. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
[TBL] [Abstract][Full Text] [Related]
3. Hormone receptor expression profile of low-grade serous ovarian cancers.
Buttarelli M; Mascilini F; Zannoni GF; Ciucci A; Martinelli E; Filippetti F; Scambia G; Ferrandina G; Gallo D
Gynecol Oncol; 2017 May; 145(2):352-360. PubMed ID: 28228232
[TBL] [Abstract][Full Text] [Related]
4. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
Yan S; Dey P; Ziegler Y; Jiao X; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS
Breast Cancer Res Treat; 2021 Jan; 185(2):281-292. PubMed ID: 33001337
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.
Leung YK; Lam HM; Wu S; Song D; Levin L; Cheng L; Wu CL; Ho SM
Endocr Relat Cancer; 2010 Sep; 17(3):675-89. PubMed ID: 20501637
[TBL] [Abstract][Full Text] [Related]
6. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
7. The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer.
Liu Z; Liao Y; Tang H; Chen G
Endocrine; 2013 Oct; 44(2):517-24. PubMed ID: 23475473
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
9. ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid.
Meligova AK; Siakouli D; Stasinopoulou S; Xenopoulou DS; Zoumpouli M; Ganou V; Gkotsi EF; Chatziioannou A; Papadodima O; Pilalis E; Alexis MN; Mitsiou DJ
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835157
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.
Schade GR; Holt SK; Zhang X; Song D; Wright JL; Zhao S; Kolb S; Lam HM; Levin L; Leung YK; Ho SM; Stanford JL
J Urol; 2016 Jun; 195(6):1760-6. PubMed ID: 26804755
[TBL] [Abstract][Full Text] [Related]
11. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
[TBL] [Abstract][Full Text] [Related]
12. The complete nuclear estrogen receptor family in the rainbow trout: discovery of the novel ERalpha2 and both ERbeta isoforms.
Nagler JJ; Cavileer T; Sullivan J; Cyr DG; Rexroad C
Gene; 2007 May; 392(1-2):164-73. PubMed ID: 17307310
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
Dey P; Jonsson P; Hartman J; Williams C; Ström A; Gustafsson JÅ
Mol Endocrinol; 2012 Dec; 26(12):1991-2003. PubMed ID: 23028063
[TBL] [Abstract][Full Text] [Related]
14. ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.
Reese JM; Suman VJ; Subramaniam M; Wu X; Negron V; Gingery A; Pitel KS; Shah SS; Cunliffe HE; McCullough AE; Pockaj BA; Couch FJ; Olson JE; Reynolds C; Lingle WL; Spelsberg TC; Goetz MP; Ingle JN; Hawse JR
BMC Cancer; 2014 Oct; 14():749. PubMed ID: 25288324
[TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.
Liu J; Sareddy GR; Zhou M; Viswanadhapalli S; Li X; Lai Z; Tekmal RR; Brenner A; Vadlamudi RK
Cancer Res; 2018 Jun; 78(12):3176-3189. PubMed ID: 29661831
[TBL] [Abstract][Full Text] [Related]
16. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
17. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.
Davies MP; O'Neill PA; Innes H; Sibson DR; Prime W; Holcombe C; Foster CS
J Mol Endocrinol; 2004 Dec; 33(3):773-82. PubMed ID: 15591034
[TBL] [Abstract][Full Text] [Related]
18. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
19. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors.
Wimberly H; Han G; Pinnaduwage D; Murphy LC; Yang XR; Andrulis IL; Sherman M; Figueroa J; Rimm DL
Breast Cancer Res Treat; 2014 Aug; 146(3):657-67. PubMed ID: 25007965
[TBL] [Abstract][Full Text] [Related]
20. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
